Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
British Journal of Cancer|February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK studyBenoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.Cell Reports. Medicine|November 15, 2023
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomasXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.Cancer Research|June 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell CarcinomaGuillaume Davidson, Alexandra Helleux, Yann A Vano, et al.Cancer Cell|July 9, 2026
GABA promotes resistance to immunotherapy in patients with TLS-positive tumorsIsaias Hernández-Verdin, Anne Calvez, Cheng-Ming Sun, et al.Nature|January 17, 2020
B cells are associated with survival and immunotherapy response in sarcomaFlorent Petitprez, Aurélien de Reyniès, Emily Z Keung, et al.Cancer Immunology Research|June 6, 2019
Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor GrowthLubka T Roumenina, Marie V Daugan, Rémi Noé, et al.The Lancet. Oncology|April 7, 2022
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trialYann-Alexandre Vano, Réza Elaidi, Mostefa Bennamoun, et al.Pageof 4